Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-11
1988-09-13
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 514333, 514256, 546277, 546270, 546256, 544333, C07D41712, A61K 3144
Patent
active
047710586
ABSTRACT:
The invention relates to a class of 3,4-diamino-1,2,5-thiadiazole-1-oxides which have histamine H.sub.1 -antagonist activity. A preferred compound of the invention is 3-[3-(5-bromo-3-methylpyrid-2-ylamino)-propylamino]-4-amino-1,2,5-thiadiaz ole-1-oxide.
REFERENCES:
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4444772 (1984-04-01), Sach
patent: 4471122 (1984-09-01), Crenshaw et al.
patent: 4486434 (1984-12-01), Sach
patent: 4532246 (1985-07-01), Ife
patent: 4532252 (1985-07-01), Sach
patent: 4537890 (1985-08-01), Sach
patent: 4537891 (1985-08-01), Sach
patent: 4547506 (1985-10-01), Ife
patent: 4548940 (1985-10-01), Ife
patent: 4692456 (1987-09-01), Ufe
Cooper David G.
Sach George S.
Fan Jane T.
Hall Linda E.
Lourie Alan D.
Smith Kline & French Laboratories Limited
Williams Janice E.
LandOfFree
3,4-diamino-1,2,5-thiadiazole-1-oxides having histamine H.sub.1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4-diamino-1,2,5-thiadiazole-1-oxides having histamine H.sub.1 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-diamino-1,2,5-thiadiazole-1-oxides having histamine H.sub.1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-807163